Tesamorelin to Improve Functional Outcomes After Peripheral Nerve Injury
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
The aim of this clinical trial is to assess the efficacy of tesamorelin as a therapy for
peripheral nerve injuries. The investigators hypothesize that treatment with tesamorelin will
allow for faster and greater recovery of motor and sensory function following surgical repair
of injured peripheral nerves. Patients with upper extremity nerve injuries will be randomly
assigned to receive either the drug or a placebo (inactive drug). A number of tests for nerve
regeneration, muscle function and sensation will be performed every month for a total of 12
months. Outcomes in the patients treated with tesamorelin will be compared to outcomes in
patients who received the placebo to determine the effectiveness of tesamorelin as a therapy
for nerve injuries.